AG˹ٷ

STOCK TITAN

[144] Hims & Hers Health, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary

Concentrix Corporation (CNXC) � Form 144 key points

An affiliate of Concentrix has filed a Form 144 indicating an intent to sell up to 300,000 common shares. With 63,025,120 shares outstanding, the proposed sale represents roughly 0.48 % of the public float. The block is valued at $18.15 million (about $60.50 per share) and is slated to be executed through Goldman Sachs & Co. LLC on or around 8 July 2025 on the NASD market.

The seller acquired the shares on 25 September 2023 as consideration in a merger or acquisition, split into two lots of 150,000 shares. In addition, the filing discloses that the same parties have already disposed of 300,000 shares during the past three months through eleven separate trades, generating gross proceeds of approximately $16.63 million.

Form 144 notices signal the intention—but not the obligation—to sell. Nevertheless, the disclosure can create near-term selling pressure and provides investors with visibility into insider disposition activity. The form contains no operating results, guidance, or other financial metrics.

Concentrix Corporation (CNXC) � Punti chiave del Modulo 144

Un affiliato di Concentrix ha presentato un Modulo 144 indicando l'intenzione di vendere fino a 300.000 azioni ordinarie. Con 63.025.120 azioni in circolazione, la vendita proposta rappresenta circa lo 0,48% del flottante pubblico. Il blocco è valutato a 18,15 milioni di dollari (circa 60,50 dollari per azione) e dovrebbe essere eseguito tramite Goldman Sachs & Co. LLC intorno all'8 luglio 2025 sul mercato NASD.

Il venditore ha acquisito le azioni il 25 settembre 2023 come corrispettivo in una fusione o acquisizione, suddivise in due lotti da 150.000 azioni ciascuno. Inoltre, il documento rivela che le stesse parti hanno già ceduto 300.000 azioni negli ultimi tre mesi attraverso undici operazioni separate, generando proventi lordi per circa 16,63 milioni di dollari.

I moduli 144 segnalano l'intenzione, ma non l'obbligo, di vendere. Tuttavia, questa comunicazione può creare una pressione di vendita a breve termine e offre agli investitori una visibilità sulle attività di disposizione da parte degli insider. Il modulo non include risultati operativi, previsioni o altri dati finanziari.

Concentrix Corporation (CNXC) � Puntos clave del Formulario 144

Un afiliado de Concentrix ha presentado un Formulario 144 indicando la intención de vender hasta 300,000 acciones comunes. Con 63,025,120 acciones en circulación, la venta propuesta representa aproximadamente el 0.48% del flotante público. El bloque está valorado en 18.15 millones de dólares (alrededor de 60.50 dólares por acción) y se planea ejecutar a través de Goldman Sachs & Co. LLC alrededor del 8 de julio de 2025 en el mercado NASD.

El vendedor adquirió las acciones el 25 de septiembre de 2023 como contraprestación en una fusión o adquisición, divididas en dos lotes de 150,000 acciones cada uno. Además, la presentación revela que las mismas partes ya han vendido 300,000 acciones en los últimos tres meses mediante once transacciones separadas, generando ingresos brutos por aproximadamente 16.63 millones de dólares.

Los formularios 144 indican la intención, pero no la obligación, de vender. Sin embargo, esta divulgación puede generar presión de venta a corto plazo y brinda a los inversores visibilidad sobre la actividad de disposición de los insiders. El formulario no contiene resultados operativos, proyecciones u otros datos financieros.

Concentrix Corporation (CNXC) � 양식 144 주요 내용

Concentrix� 계열사가 최대 300,000 보통주를 판매� 의사� 나타내는 양식 144� 제출했습니다. 63,025,120 주의 발행 주식� 고려� �, 이번 제안� 매도� 대� 공개 유통 주식� 0.48%� 해당합니�. 해당 블록� 가치는 1,815� 달러 (주당 � 60.50 달러)이며, 2025� 7� 8일경 NASD 시장에서 골드� 삭스 & 컴퍼� LLC� 통해 실행� 예정입니�.

판매자는 2023� 9� 25� 합병 또는 인수 대가� 주식� 취득했으�, 150,000주씩 � 번에 나누� 보유하고 있습니다. 또한 제출 서류� 따르� 동일� 당사자들� 최근 3개월 동안 300,000주를 이미 11건의 별도 거래� 통해 매도하여 � � 1,663� 달러� 총수익을 올렸�� 밝혔습니�.

양식 144� 판매 의사� 나타� �, 의무� 아닙니다. 그럼에도 불구하고, � 공시� 단기 매도 압력� 유발� � 있으�, 투자자들에게 내부� 매도 활동� 대� 가시성� 제공합니�. � 양식에는 영업 실적, 전망 또는 기타 재무 지표는 포함되어 있지 않습니다.

Concentrix Corporation (CNXC) � Points clés du formulaire 144

Un affilié de Concentrix a déposé un formulaire 144 indiquant une intention de vendre jusqu'à 300 000 actions ordinaires. Avec 63 025 120 actions en circulation, la vente proposée représente environ 0,48 % du flottant public. Le bloc est évalué à 18,15 millions de dollars (environ 60,50 dollars par action) et devrait être exécuté par Goldman Sachs & Co. LLC aux alentours du 8 juillet 2025 sur le marché NASD.

Le vendeur a acquis les actions le 25 septembre 2023 en contrepartie d'une fusion ou acquisition, réparties en deux lots de 150 000 actions. De plus, le dépôt révèle que les mêmes parties ont déjà cédé 300 000 actions au cours des trois derniers mois via onze transactions distinctes, générant un produit brut d'environ 16,63 millions de dollars.

Les formulaires 144 signalent l'intention, mais pas l'obligation, de vendre. Néanmoins, cette divulgation peut créer une pression de vente à court terme et offre aux investisseurs une visibilité sur l'activité de cession des initiés. Le formulaire ne contient aucun résultat opérationnel, prévisions ou autres indicateurs financiers.

Concentrix Corporation (CNXC) � Wichtige Punkte zum Formular 144

Ein verbundenes Unternehmen von Concentrix hat ein Formular 144 eingereicht, das die Absicht zum Verkauf von bis zu 300.000 Stammaktien anzeigt. Bei 63.025.120 ausstehenden Aktien entspricht der vorgeschlagene Verkauf etwa 0,48 % der frei handelbaren Aktien. Das Paket hat einen Wert von 18,15 Millionen US-Dollar (etwa 60,50 US-Dollar pro Aktie) und soll über Goldman Sachs & Co. LLC am oder um den 8. Juli 2025 am NASD-Markt ausgeführt werden.

Der Verkäufer erwarb die Aktien am 25. September 2023 als Gegenleistung bei einer Fusion oder Übernahme, aufgeteilt in zwei Tranchen zu je 150.000 Aktien. Zudem offenbart die Meldung, dass die gleichen Parteien bereits in den letzten drei Monaten 300.000 Aktien in elf separaten Transaktionen verkauft haben, wodurch Bruttoerlöse von etwa 16,63 Millionen US-Dollar erzielt wurden.

Formulare 144 signalisieren die Absicht, aber nicht die Verpflichtung zum Verkauf. Dennoch kann die Offenlegung kurzfristigen Verkaufsdruck erzeugen und bietet Investoren Einblick in Insider-Verkaufsaktivitäten. Das Formular enthält keine Betriebsergebnisse, Prognosen oder andere finanzielle Kennzahlen.

Positive
  • None.
Negative
  • Planned insider sale of 300,000 shares (~0.48 % of shares outstanding) could create short-term selling pressure and be perceived as reduced insider confidence.
  • Continuation of insider dispositions�300,000 shares already sold in the past three months—may amplify negative sentiment regarding insider outlook.

Insights

TL;DR: Insider plans further 300k-share sale (~0.5% float); continuation of recent disposals may weigh on sentiment.

The filing reveals that an insider or affiliate seeks to liquidate another 300,000 CNXC shares, following an identical amount sold in the prior quarter. Although 0.48 % of outstanding shares is modest, cumulative insider selling of 600,000 shares within four months can raise concerns about management’s outlook and place incremental supply on the market. At the declared $60.5 reference price, proceeds total roughly $18 million—immaterial to the company but meaningful for daily trading volumes. Investors often view concentrated insider sales as a negative signal absent offsetting bullish disclosures.

TL;DR: Filing shows Rule 144 compliance; signals transparency despite insider selling trend.

The Form 144 demonstrates adherence to SEC Rule 144 requirements, highlighting procedural integrity. However, governance analysts track the pattern: the same entities sold 300,000 shares recently and now plan another tranche. While legal, sustained insider selling can be construed as misalignment with long-term shareholder interests, particularly without complementary share-retention commitments or performance disclosures. From a governance lens, the impact is moderately negative but not alarming given the modest percentage of float.

Concentrix Corporation (CNXC) � Punti chiave del Modulo 144

Un affiliato di Concentrix ha presentato un Modulo 144 indicando l'intenzione di vendere fino a 300.000 azioni ordinarie. Con 63.025.120 azioni in circolazione, la vendita proposta rappresenta circa lo 0,48% del flottante pubblico. Il blocco è valutato a 18,15 milioni di dollari (circa 60,50 dollari per azione) e dovrebbe essere eseguito tramite Goldman Sachs & Co. LLC intorno all'8 luglio 2025 sul mercato NASD.

Il venditore ha acquisito le azioni il 25 settembre 2023 come corrispettivo in una fusione o acquisizione, suddivise in due lotti da 150.000 azioni ciascuno. Inoltre, il documento rivela che le stesse parti hanno già ceduto 300.000 azioni negli ultimi tre mesi attraverso undici operazioni separate, generando proventi lordi per circa 16,63 milioni di dollari.

I moduli 144 segnalano l'intenzione, ma non l'obbligo, di vendere. Tuttavia, questa comunicazione può creare una pressione di vendita a breve termine e offre agli investitori una visibilità sulle attività di disposizione da parte degli insider. Il modulo non include risultati operativi, previsioni o altri dati finanziari.

Concentrix Corporation (CNXC) � Puntos clave del Formulario 144

Un afiliado de Concentrix ha presentado un Formulario 144 indicando la intención de vender hasta 300,000 acciones comunes. Con 63,025,120 acciones en circulación, la venta propuesta representa aproximadamente el 0.48% del flotante público. El bloque está valorado en 18.15 millones de dólares (alrededor de 60.50 dólares por acción) y se planea ejecutar a través de Goldman Sachs & Co. LLC alrededor del 8 de julio de 2025 en el mercado NASD.

El vendedor adquirió las acciones el 25 de septiembre de 2023 como contraprestación en una fusión o adquisición, divididas en dos lotes de 150,000 acciones cada uno. Además, la presentación revela que las mismas partes ya han vendido 300,000 acciones en los últimos tres meses mediante once transacciones separadas, generando ingresos brutos por aproximadamente 16.63 millones de dólares.

Los formularios 144 indican la intención, pero no la obligación, de vender. Sin embargo, esta divulgación puede generar presión de venta a corto plazo y brinda a los inversores visibilidad sobre la actividad de disposición de los insiders. El formulario no contiene resultados operativos, proyecciones u otros datos financieros.

Concentrix Corporation (CNXC) � 양식 144 주요 내용

Concentrix� 계열사가 최대 300,000 보통주를 판매� 의사� 나타내는 양식 144� 제출했습니다. 63,025,120 주의 발행 주식� 고려� �, 이번 제안� 매도� 대� 공개 유통 주식� 0.48%� 해당합니�. 해당 블록� 가치는 1,815� 달러 (주당 � 60.50 달러)이며, 2025� 7� 8일경 NASD 시장에서 골드� 삭스 & 컴퍼� LLC� 통해 실행� 예정입니�.

판매자는 2023� 9� 25� 합병 또는 인수 대가� 주식� 취득했으�, 150,000주씩 � 번에 나누� 보유하고 있습니다. 또한 제출 서류� 따르� 동일� 당사자들� 최근 3개월 동안 300,000주를 이미 11건의 별도 거래� 통해 매도하여 � � 1,663� 달러� 총수익을 올렸�� 밝혔습니�.

양식 144� 판매 의사� 나타� �, 의무� 아닙니다. 그럼에도 불구하고, � 공시� 단기 매도 압력� 유발� � 있으�, 투자자들에게 내부� 매도 활동� 대� 가시성� 제공합니�. � 양식에는 영업 실적, 전망 또는 기타 재무 지표는 포함되어 있지 않습니다.

Concentrix Corporation (CNXC) � Points clés du formulaire 144

Un affilié de Concentrix a déposé un formulaire 144 indiquant une intention de vendre jusqu'à 300 000 actions ordinaires. Avec 63 025 120 actions en circulation, la vente proposée représente environ 0,48 % du flottant public. Le bloc est évalué à 18,15 millions de dollars (environ 60,50 dollars par action) et devrait être exécuté par Goldman Sachs & Co. LLC aux alentours du 8 juillet 2025 sur le marché NASD.

Le vendeur a acquis les actions le 25 septembre 2023 en contrepartie d'une fusion ou acquisition, réparties en deux lots de 150 000 actions. De plus, le dépôt révèle que les mêmes parties ont déjà cédé 300 000 actions au cours des trois derniers mois via onze transactions distinctes, générant un produit brut d'environ 16,63 millions de dollars.

Les formulaires 144 signalent l'intention, mais pas l'obligation, de vendre. Néanmoins, cette divulgation peut créer une pression de vente à court terme et offre aux investisseurs une visibilité sur l'activité de cession des initiés. Le formulaire ne contient aucun résultat opérationnel, prévisions ou autres indicateurs financiers.

Concentrix Corporation (CNXC) � Wichtige Punkte zum Formular 144

Ein verbundenes Unternehmen von Concentrix hat ein Formular 144 eingereicht, das die Absicht zum Verkauf von bis zu 300.000 Stammaktien anzeigt. Bei 63.025.120 ausstehenden Aktien entspricht der vorgeschlagene Verkauf etwa 0,48 % der frei handelbaren Aktien. Das Paket hat einen Wert von 18,15 Millionen US-Dollar (etwa 60,50 US-Dollar pro Aktie) und soll über Goldman Sachs & Co. LLC am oder um den 8. Juli 2025 am NASD-Markt ausgeführt werden.

Der Verkäufer erwarb die Aktien am 25. September 2023 als Gegenleistung bei einer Fusion oder Übernahme, aufgeteilt in zwei Tranchen zu je 150.000 Aktien. Zudem offenbart die Meldung, dass die gleichen Parteien bereits in den letzten drei Monaten 300.000 Aktien in elf separaten Transaktionen verkauft haben, wodurch Bruttoerlöse von etwa 16,63 Millionen US-Dollar erzielt wurden.

Formulare 144 signalisieren die Absicht, aber nicht die Verpflichtung zum Verkauf. Dennoch kann die Offenlegung kurzfristigen Verkaufsdruck erzeugen und bietet Investoren Einblick in Insider-Verkaufsaktivitäten. Das Formular enthält keine Betriebsergebnisse, Prognosen oder andere finanzielle Kennzahlen.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

How many Concentrix (CNXC) shares are insiders planning to sell according to the Form 144?

The notice covers 300,000 common shares valued at about $18.15 million.

What percentage of Concentrix’s outstanding shares does the 300,000-share block represent?

It equals roughly 0.48 % of the 63,025,120 shares outstanding.

When is the proposed sale date for the CNXC shares?

The approximate sale date listed is July 8, 2025.

Which broker is handling the planned insider sale for Concentrix?

The shares are to be sold through Goldman Sachs & Co. LLC.

Have there been recent insider sales of CNXC stock prior to this filing?

Yes. The same parties sold 300,000 shares over the last three months, generating about $16.63 million in proceeds.
Hims & Hers Health Inc

NYSE:HIMS

HIMS Rankings

HIMS Latest News

HIMS Latest SEC Filings

HIMS Stock Data

10.73B
190.62M
11.25%
79.06%
23.34%
Household & Personal Products
Services-offices & Clinics of Doctors of Medicine
United States
SAN FRANCISCO